BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23207485)

  • 1. Increased glutaminyl cyclase expression in peripheral blood of Alzheimer's disease patients.
    Valenti MT; Bolognin S; Zanatta C; Donatelli L; Innamorati G; Pampanin M; Zanusso G; Zatta P; Dalle Carbonare L
    J Alzheimers Dis; 2013; 34(1):263-71. PubMed ID: 23207485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-β load and cognitive decline in Alzheimer's disease.
    Morawski M; Schilling S; Kreuzberger M; Waniek A; Jäger C; Koch B; Cynis H; Kehlen A; Arendt T; Hartlage-Rübsamen M; Demuth HU; Roßner S
    J Alzheimers Dis; 2014; 39(2):385-400. PubMed ID: 24164736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology.
    Schilling S; Zeitschel U; Hoffmann T; Heiser U; Francke M; Kehlen A; Holzer M; Hutter-Paier B; Prokesch M; Windisch M; Jagla W; Schlenzig D; Lindner C; Rudolph T; Reuter G; Cynis H; Montag D; Demuth HU; Rossner S
    Nat Med; 2008 Oct; 14(10):1106-11. PubMed ID: 18836460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice.
    Jawhar S; Wirths O; Schilling S; Graubner S; Demuth HU; Bayer TA
    J Biol Chem; 2011 Feb; 286(6):4454-60. PubMed ID: 21148560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta.
    Cynis H; Scheel E; Saido TC; Schilling S; Demuth HU
    Biochemistry; 2008 Jul; 47(28):7405-13. PubMed ID: 18570439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients.
    Hu N; Tan MS; Yu JT; Sun L; Tan L; Wang YL; Jiang T; Tan L
    J Alzheimers Dis; 2014; 38(3):497-501. PubMed ID: 24002183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of glutaminyl cyclase inhibitors for Alzheimer's disease.
    Coimbra JR; Sobral PJ; Santos AE; Moreira PI; Salvador JA
    Future Med Chem; 2019 Dec; 11(24):3179-3194. PubMed ID: 31838899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease.
    Vijayan DK; Zhang KYJ
    Pharmacol Res; 2019 Sep; 147():104342. PubMed ID: 31288079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in mRNA expression of BACE1, cathepsin B, and glutaminyl cyclase in mice ischemic brain.
    Ye JT; Pi RB; Mao XX; Chen XH; Qin J; Xu SW; Liu PQ
    Neuroreport; 2009 Oct; 20(16):1456-60. PubMed ID: 19809370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.
    Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU
    Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study.
    Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T
    J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients.
    Le Bastard N; Leurs J; Blomme W; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2010; 21(1):291-301. PubMed ID: 20421698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed Ca2+ homeostasis increases glutaminyl cyclase expression; connecting two early pathogenic events in Alzheimer's disease in vitro.
    De Kimpe L; Bennis A; Zwart R; van Haastert ES; Hoozemans JJ; Scheper W
    PLoS One; 2012; 7(9):e44674. PubMed ID: 22970285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals.
    Gunn AP; Wong BX; McLean C; Fowler C; Barnard PJ; Duce JA; Roberts BR;
    J Neurochem; 2021 Mar; 156(6):979-987. PubMed ID: 32614980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amyloid-β oligomer count in cerebrospinal fluid is a biomarker for Alzheimer's disease.
    Wang-Dietrich L; Funke SA; Kühbach K; Wang K; Besmehn A; Willbold S; Cinar Y; Bannach O; Birkmann E; Willbold D
    J Alzheimers Dis; 2013; 34(4):985-94. PubMed ID: 23313925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte Telomere Length in Alzheimer's Disease Patients with a Different Rate of Progression.
    Tedone E; Arosio B; Colombo F; Ferri E; Asselineau D; Piette F; Gussago C; Belmin J; Pariel S; Benlhassan K; Casati M; Bornand A; Rossi PD; Mazzola P; Annoni G; Doulazmi M; Mariani J; Porretti L; Bray DH; Mari D
    J Alzheimers Dis; 2015; 46(3):761-9. PubMed ID: 26402514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated NF-κB pathway in peripheral mononuclear cells of Alzheimer's disease patients.
    Ascolani A; Balestrieri E; Minutolo A; Mosti S; Spalletta G; Bramanti P; Mastino A; Caltagirone C; Macchi B
    Curr Alzheimer Res; 2012 Jan; 9(1):128-37. PubMed ID: 21592054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of thyrotropin-releasing hormone as hippocampal glutaminyl cyclase substrate in neurons and reactive astrocytes.
    Waniek A; Hartlage-Rübsamen M; Höfling C; Kehlen A; Schilling S; Demuth HU; Roßner S
    Biochim Biophys Acta; 2015 Jan; 1852(1):146-55. PubMed ID: 25446989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of CD33 in peripheral mononuclear cells of Alzheimer's disease patients.
    Hu N; Tan MS; Sun L; Jiang T; Wang YL; Tan L; Zhang W; Yu JT; Tan L
    Neurosci Lett; 2014 Mar; 563():51-4. PubMed ID: 24412678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.